title: Prevention of graft rejection by donor type II CD8(+) T cells (Tc2 cells) is not sufficient to improve engraftment in fetal transplantation.
abstract: OBJECTIVE
  Tc2 cells, a subset of CD8(+) T cells, are able to facilitate engraftment in a murine model of postnatal allogeneic bone marrow transplantation. The purpose of this study was to evaluate whether Tc2 cells could improve engraftment in fetal transplantation.
  
  
  METHODS
  Gestational day 13 C57BL/6 (H-2(b)) fetal mice were used as recipients, adult B6D2F(1) mice (C57BL/6 x DBA/2, H-2(b/d)) as donors, and splenocytes from B6C3F(1) (C57BL/6 x C3H/He, H-2(b/k)) mice were used as stimulators in cultures used to generate the Tc2 cells from B6D2F(1) mice. Peripheral blood chimerism was examined monthly for 3 months. Thereafter, recipients were sacrificed to evaluate the levels of peritoneal, splenic and bone marrow chimerism. The T-cell responses of recipient splenocytes to cells of host origin were measured as a proliferative response in mixed lymphocyte cultures.
  
  
  RESULTS
  Low levels of peripheral blood cell chimerism (<0.3%) were observed at 1 month of age, which declined further by 3 months of age. The levels of donor cells in the spleen, bone marrow and peritoneal cavity were usually not more than 0.05%. The peritoneal cavity tended to have higher levels of donor cells with 1 recipient sustaining as high as 25.03% at the age of 3 months. Higher peritoneal chimerism correlated with a lower donor-specific T-cell response.
  
  
  CONCLUSIONS
  Transplantation of Tc2 cells was insufficient to improve bone marrow engraftment in utero, suggesting that graft rejection is not the major barrier to successful in utero transplantation. Donor cells can persist in the peritoneal cavity and might play an important role in inducing immune tolerance in fetuses.
authors.affiliation: Fetal Treatment Center, Department of Surgery, University of California, San Francisco, CA 94143, USA.
authors.forename: Jeng-Chang
authors.initials: JC
authors.lastname: Chen
authors.forename: Ming-Ling
authors.initials: ML
authors.lastname: Chang
authors.forename: Hanmin
authors.initials: H
authors.lastname: Lee
authors.forename: Marcus O
authors.initials: MO
authors.lastname: Muench
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000637:transplantation*; D002478:Cells, Cultured; D005333:Fetus / Q000601:surgery*; D006084:Graft Rejection / Q000517:prevention & control*; D051379:Mice; D008815:Mice, Inbred Strains; D016019:Survival Analysis; D014019:Tissue Donors; D018183:Transplantation Chimera; D023001:Transplantation Tolerance